Proximal Onyx embolization of the middle meningeal artery (POEM) technique for non-acute subdural hematomas: a single-center study of 123 patients using the Scepter dual-lumen balloon microcatheter.

IF 4.3 1区 医学 Q1 NEUROIMAGING
Aliana Rao, Samuel L Ricci, Theodore C Hannah, Erin K M Graves, Anand Kaul, Eric T Quach, Rami O Almefty, Kadir Erkmen
{"title":"Proximal Onyx embolization of the middle meningeal artery (POEM) technique for non-acute subdural hematomas: a single-center study of 123 patients using the Scepter dual-lumen balloon microcatheter.","authors":"Aliana Rao, Samuel L Ricci, Theodore C Hannah, Erin K M Graves, Anand Kaul, Eric T Quach, Rami O Almefty, Kadir Erkmen","doi":"10.1136/jnis-2025-023999","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Non-acute subdural hematomas (NASDHs) often recur or persist, particularly among older patients with comorbidities. Middle meningeal artery embolization (MMAe) has emerged as a promising primary treatment alternative. Dual-lumen balloon microcatheters significantly reduce the risk of reflux, which is a limitation of single-lumen microcatheters. We evaluated the safety and efficacy of the proximal Onyx embolization of the MMA (POEM) technique using the Scepter Mini and Scepter XC balloon microcatheters.</p><p><strong>Methods: </strong>We conducted a single-center retrospective review of patients with NASDH undergoing Onyx MMAe with the Scepter Mini or Scepter XC microcatheter between July 2020 and January 2025. Demographics, imaging parameters (hematoma thickness, midline shift), procedural details, and clinical and radiographic outcomes were recorded.</p><p><strong>Results: </strong>123 patients underwent Scepter balloon-assisted MMAe. Their mean age was 72 years and 67.5% were male. At 6 months, 77.2% achieved ≥50% reduction in hematoma thickness. There were no significant differences in baseline demographics, hematoma characteristics, or surgical intervention rates between patients achieving ≥50% reduction and those with <50%. Five patients (4.1%) experienced recurrence, with average time to recurrence of 76 days. Only three patients (2.4%) required surgical rescue. Safety outcomes included 6.5% all-cause mortality at 180 days, with 1.6% directly related to NASDH. Stroke occurred in 1.6% at 30 days and 4.1% at 180 days.</p><p><strong>Conclusion: </strong>By minimizing the risk of reflux, balloon-assisted MMAe allows for safe embolization from a more proximal location. The POEM technique shows that proximal embolization with dual-lumen balloon microcatheters treats NASDH effectively, achieving substantial hematoma resolution with low recurrence. Prospective studies comparing POEM with other techniques are warranted to confirm its comparative efficacy.</p>","PeriodicalId":16411,"journal":{"name":"Journal of NeuroInterventional Surgery","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of NeuroInterventional Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnis-2025-023999","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Non-acute subdural hematomas (NASDHs) often recur or persist, particularly among older patients with comorbidities. Middle meningeal artery embolization (MMAe) has emerged as a promising primary treatment alternative. Dual-lumen balloon microcatheters significantly reduce the risk of reflux, which is a limitation of single-lumen microcatheters. We evaluated the safety and efficacy of the proximal Onyx embolization of the MMA (POEM) technique using the Scepter Mini and Scepter XC balloon microcatheters.

Methods: We conducted a single-center retrospective review of patients with NASDH undergoing Onyx MMAe with the Scepter Mini or Scepter XC microcatheter between July 2020 and January 2025. Demographics, imaging parameters (hematoma thickness, midline shift), procedural details, and clinical and radiographic outcomes were recorded.

Results: 123 patients underwent Scepter balloon-assisted MMAe. Their mean age was 72 years and 67.5% were male. At 6 months, 77.2% achieved ≥50% reduction in hematoma thickness. There were no significant differences in baseline demographics, hematoma characteristics, or surgical intervention rates between patients achieving ≥50% reduction and those with <50%. Five patients (4.1%) experienced recurrence, with average time to recurrence of 76 days. Only three patients (2.4%) required surgical rescue. Safety outcomes included 6.5% all-cause mortality at 180 days, with 1.6% directly related to NASDH. Stroke occurred in 1.6% at 30 days and 4.1% at 180 days.

Conclusion: By minimizing the risk of reflux, balloon-assisted MMAe allows for safe embolization from a more proximal location. The POEM technique shows that proximal embolization with dual-lumen balloon microcatheters treats NASDH effectively, achieving substantial hematoma resolution with low recurrence. Prospective studies comparing POEM with other techniques are warranted to confirm its comparative efficacy.

近端Onyx栓塞脑膜中动脉(POEM)技术治疗非急性硬膜下血肿:一项123例使用Scepter双腔球囊微导管的单中心研究。
目的:非急性硬膜下血肿(NASDHs)经常复发或持续存在,特别是在有合并症的老年患者中。脑膜中动脉栓塞(MMAe)已成为一种有希望的主要治疗方案。双腔球囊微导管可显著降低反流风险,这是单腔微导管的局限性。我们使用Scepter Mini和Scepter XC球囊微导管评估近端Onyx栓塞MMA (POEM)技术的安全性和有效性。方法:我们对2020年7月至2025年1月期间使用Scepter Mini或Scepter XC微导管接受Onyx MMAe治疗的NASDH患者进行了单中心回顾性研究。记录人口统计学、影像学参数(血肿厚度、中线移位)、手术细节以及临床和影像学结果。结果:123例患者行权杖球囊辅助MMAe。平均年龄72岁,男性占67.5%。6个月时,77.2%的患者血肿厚度减少≥50%。结论:通过最小化反流风险,球囊辅助MMAe允许从更近端的位置进行安全栓塞,球囊辅助MMAe允许从更近端的位置进行安全栓塞。POEM技术显示,双腔球囊微导管近端栓塞治疗NASDH有效,血肿消退明显,复发率低。前瞻性研究将POEM与其他技术进行比较,以证实其相对疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.50
自引率
14.60%
发文量
291
审稿时长
4-8 weeks
期刊介绍: The Journal of NeuroInterventional Surgery (JNIS) is a leading peer review journal for scientific research and literature pertaining to the field of neurointerventional surgery. The journal launch follows growing professional interest in neurointerventional techniques for the treatment of a range of neurological and vascular problems including stroke, aneurysms, brain tumors, and spinal compression.The journal is owned by SNIS and is also the official journal of the Interventional Chapter of the Australian and New Zealand Society of Neuroradiology (ANZSNR), the Canadian Interventional Neuro Group, the Hong Kong Neurological Society (HKNS) and the Neuroradiological Society of Taiwan.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信